Weili Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Weili Zheng has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Jihwan Park
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
2 shared publications- Michael Chilazi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications - Seth Shay Martin
Johns Hopkins University School of Medicine
2 shared publications Steven R. Jones
Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publications- Allan S. Jaffe
Departments of Cardiology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (A.S.J.).
1 shared publication - An Qin
Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI
1 shared publication
Latest Publications
- 1 May 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (5) , 400-402
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression
- 1 May 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (5) , 400-402
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression
- 12 February 2022
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 16 (2) , 220-226
Quantifying the contribution of lipoprotein(a) to all apoB containing particles
- 12 February 2022
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 16 (2) , 220-226
Quantifying the contribution of lipoprotein(a) to all apoB containing particles
- Open Access
- 18 January 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (2) , e023136
Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
Background: Accurate measurement of the cholesterol within lipoprotein(a) (Lp[a]‐C) and its contribution to low‐density lipoprotein cholesterol (LDL‐C) has important implications for risk assessment, diagnosis, and treatment of atherosclerotic cardiovascular disease, as well as in familial hypercholesterolemia. A method for estimating Lp(a)‐C from particle number using fixed conversion factors has been proposed (Lp[a]‐C from particle number divided by 2.4 for Lp(a) mass, multiplied by 30% for Lp[a]‐C). The accuracy of this method, which theoretically can isolate “Lp(a)‐free LDL‐C,” has not been validated. Methods and Results: In 177 875 patients from the VLDbL (Very Large Database of Lipids), we compared estimated Lp(a)‐C and Lp(a)‐free LDL‐C with measured values and quantified absolute and percent error. We compared findings with an analogous data set from the Mayo Clinic Laboratory. Error in estimated Lp(a)‐C and Lp(a)‐free LDL‐C increased with higher Lp(a)‐C values. Median error for estimated Lp(a)‐C <10 mg/dL was −1.9 mg/dL (interquartile range, −4.0 to 0.2); this error increased linearly, overestimating by +30.8 mg/dL (interquartile range, 26.1–36.5) for estimated Lp(a)‐C ≥50 mg/dL. This error relationship persisted after stratification by overall high‐density lipoprotein cholesterol and high‐density lipoprotein cholesterol subtypes. Similar findings were observed in the Mayo cohort. Absolute error for Lp(a)‐free LDL‐C was +2.4 (interquartile range, −0.6 to 5.3) for Lp(a)‐C<10 mg/dL and −31.8 (interquartile range, −37.8 to −26.5) mg/dL for Lp(a)‐C≥50 mg/dL. Conclusions: Lp(a)‐C estimations using fixed conversion factors overestimated Lp(a)‐C and subsequently underestimated Lp(a)‐free LDL‐C, especially at clinically relevant Lp(a) values. Application of inaccurate Lp(a)‐C estimations to correct LDL‐C may lead to undertreatment of high‐risk patients.
- 18 January 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (2) , e023136
Open AccessAssessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
Background: Accurate measurement of the cholesterol within lipoprotein(a) (Lp[a]‐C) and its contribution to low‐density lipoprotein cholesterol (LDL‐C) has important implications for risk assessment, diagnosis, and treatment of atherosclerotic cardiovascular disease, as well as in familial hypercholesterolemia. A method for estimating Lp(a)‐C from particle number using fixed conversion factors has been proposed (Lp[a]‐C from particle number divided by 2.4 for Lp(a) mass, multiplied by 30% for Lp[a]‐C). The accuracy of this method, which theoretically can isolate “Lp(a)‐free LDL‐C,” has not been validated. Methods and Results: In 177 875 patients from the VLDbL (Very Large Database of Lipids), we compared estimated Lp(a)‐C and Lp(a)‐free LDL‐C with measured values and quantified absolute and percent error. We compared findings with an analogous data set from the Mayo Clinic Laboratory. Error in estimated Lp(a)‐C and Lp(a)‐free LDL‐C increased with higher Lp(a)‐C values. Median error for estimated Lp(a)‐C <10 mg/dL was −1.9 mg/dL (interquartile range, −4.0 to 0.2); this error increased linearly, overestimating by +30.8 mg/dL (interquartile range, 26.1–36.5) for estimated Lp(a)‐C ≥50 mg/dL. This error relationship persisted after stratification by overall high‐density lipoprotein cholesterol and high‐density lipoprotein cholesterol subtypes. Similar findings were observed in the Mayo cohort. Absolute error for Lp(a)‐free LDL‐C was +2.4 (interquartile range, −0.6 to 5.3) for Lp(a)‐C<10 mg/dL and −31.8 (interquartile range, −37.8 to −26.5) mg/dL for Lp(a)‐C≥50 mg/dL. Conclusions: Lp(a)‐C estimations using fixed conversion factors overestimated Lp(a)‐C and subsequently underestimated Lp(a)‐free LDL‐C, especially at clinically relevant Lp(a) values. Application of inaccurate Lp(a)‐C estimations to correct LDL‐C may lead to undertreatment of high‐risk patients.
- 1 May 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (4) , 2407-2412
Synthesis of flexible magnetic nanohybrid based on bacterial cellulose under ultrasonic irradiation
- 1 May 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (4) , 2407-2412
Synthesis of flexible magnetic nanohybrid based on bacterial cellulose under ultrasonic irradiation